(Q28375634)

English

Risperidone treatment of drug-related psychosis in patients with parkinsonism

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Risperidone treatment of drug-related psychosis in patients with parkinsonism (English)

0 references

1 reference

2 references

1 reference

parkinsonian syndrome

1 reference

N A Leopold

1

0 references

language of work or name

English

0 references

publication date

March 2000

0 references

published in

Movement Disorders

0 references

volume

15

0 references

page(s)

301-4

0 references

issue

2

0 references

cites work

Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C301%3A%3AAID-MDS1014%3E3.0.CO%3B2-2

retrieved

21 January 2018

Parkinsonism: onset, progression, and mortality

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C301%3A%3AAID-MDS1014%3E3.0.CO%3B2-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C301%3A%3AAID-MDS1014%3E3.0.CO%3B2-2

retrieved

21 January 2018

Clozapine. A novel antipsychotic agent

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C301%3A%3AAID-MDS1014%3E3.0.CO%3B2-2

retrieved

21 January 2018

Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C301%3A%3AAID-MDS1014%3E3.0.CO%3B2-2

retrieved

21 January 2018

Risperidone for hallucinations in levodopa-treated Parkinson's disease patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C301%3A%3AAID-MDS1014%3E3.0.CO%3B2-2

retrieved

21 January 2018

Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C301%3A%3AAID-MDS1014%3E3.0.CO%3B2-2

retrieved

21 January 2018

Therapeutic dilemma: psychosis and Parkinson's disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C301%3A%3AAID-MDS1014%3E3.0.CO%3B2-2

retrieved

21 January 2018

Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C301%3A%3AAID-MDS1014%3E3.0.CO%3B2-2

retrieved

21 January 2018

Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C301%3A%3AAID-MDS1014%3E3.0.CO%3B2-2

retrieved

21 January 2018

Identifiers

DOI

10.1002/1531-8257(200003)15:2<301::AID-MDS1014>3.0.CO;2-2

0 references

PubMed ID

10752580

0 references

(Q28375634)

Risperidone treatment of drug-related psychosis in patients with parkinsonism

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)